Canopy Growth (TSX:WEED) Stock: Why I Finally Bought Some

Why now is the time to buy some Canopy Growth Corp (TSX:WEED)(NYSE:CGC) shares.

| More on:
Cannabis stocks have fallen.

The cannabis industry is relatively new with a lot of unknowns and uncertainties. Therefore, investing in weed stocks is speculative.

However, if you want to participate in the high-growth industry, and it isn’t a good opportunity to buy a global leader and the dominant player in the country (i.e., Canopy Growth (TSX:WEED)(NYSE:CGC)) after the stock has corrected by more than 50% from its high, I don’t know what is.

WEED Chart

WEED data by YCharts.

Analysts have an average price target of $56.60 per share on WEED stock, which represents a discount of more than 40% or upside potential of 77%!

Recent highlights

For fiscal first-quarter 2020, Canopy Growth reported net revenue of $90.5 million, which was up 249% against the comparable quarter a year ago. The company increased dried cannabis sales in the Canadian recreational market by 94% over Q4 2019 and increased international medical cannabis revenue by 209% versus Q1 2019.

Canopy Growth harvested 40,960 kilograms, an increase of 183% over the prior quarter. This greatly exceeded its prior estimate of 34,000 kilograms. This is significant because the first-quarter harvest was the first full-scale harvest since it began retrofitting its large-scale greenhouse facilities in 2018, and with the majority of the work completed at the facilities, Canopy Growth will be shifting its focus on optimization to increase yield and lower cost.

In the quarter, Canopy Growth filed 56 patent applications, bringing the company’s patent portfolio to an industry-leading 111 patents and 270 patent applications.

Why the stock correction is a buying opportunity

What might have driven the stock lower is the gross margin compression; the margin fell from 43% a year ago to 15%.

Canopy Growth explained that the lower margin was predominantly due to operating costs related to facilities that haven’t begun production yet and a shift in product mix.

WEED’s gross margin should rebound meaningfully in subsequent quarters. In a recent press release, the company’s CEO, Mark Zekulin had a positive tone stating, “Fiscal 2020 is going to be another exciting time for the cannabis industry as we close in on the launch of new product formats. Our recent harvests are proof that our focus on operational excellence is working, and we look forward to showing both our Canadian and U.S. customers what we’ve been working on behind the scenes to prepare for the next wave of products coming later this year.”

Investor takeaway

At under $32 per share as of writing, WEED stock trades at about 34 times sales and two times book, which is a massive discount of 74% and 61%, respectively, from its five-year multiples. So, now is an opportunistic entry point for investors with a big appetite for risk and volatility and have an investment horizon of at least three years.

I fully expect WEED stock to be a bumpy ride. And that’s why I only bought a third of a position with room to add should it fall some more. If not, I’m happy trading this for short-term gains should the stock move materially higher.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Kay Ng owns shares of Canopy Growth.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »